| 000 | 01456 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515170232.0 | ||
| 264 | 0 | _c20090609 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1875-9114 | ||
| 024 | 7 |
_a10.1592/phco.29.5.578 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScarpace, Sarah L | |
| 245 | 0 | 0 |
_aTreatment of head and neck cancers: issues for clinical pharmacists. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cMay 2009 |
||
| 300 |
_a578-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDermatitis _xetiology |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedication Therapy Management |
| 650 | 0 | 4 |
_aMucositis _xetiology |
| 650 | 0 | 4 | _aPharmaceutical Services |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aXerostomia _xetiology |
| 700 | 1 | _aBrodzik, Frank A | |
| 700 | 1 | _aMehdi, Syed | |
| 700 | 1 | _aBelgam, Robert | |
| 773 | 0 |
_tPharmacotherapy _gvol. 29 _gno. 5 _gp. 578-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.29.5.578 _zAvailable from publisher's website |
| 999 |
_c18827766 _d18827766 |
||